NEW YORK (GenomeWeb News) — Digilab BioVision today said it will offer GenWay Biotech’s Seppro IgY proteomics technology from its Hannover, Germany, facility.
 
Digilab said Seppro’s IgY technology selectively partitions the 12 most abundant proteins from human serum or plasma.
 
Digilab said its Peptidomics products and services increase the sensitivity and selectivity needed for drug-development proteomics.
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.